Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Marion, Kuper"'
Autor:
Ross Lawrenson, Chunhuan Lao, James Stanley, Andrea Teng, Marion Kuper‐Hommel, Ian Campbell, Jeremy Krebs, Dianne Sika‐Paotonu, Jonathan Koea, Ineke Meredith, Jason Gurney
Publikováno v:
Cancer Reports, Vol 7, Iss 3, Pp n/a-n/a (2024)
Abstract Objectives The objective of this study is to investigate the influence of diabetes on breast cancer‐specific survival among women with breast cancer in Aotearoa/New Zealand. Methods This study included women diagnosed with invasive breast
Externí odkaz:
https://doaj.org/article/ad4aae2c1175490a96810fdd4dd46540
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Obesity has been reported as an adverse prognostic factor in breast cancer, but inconsistently, and under-treatment with chemotherapy may occur. We provide the first assessment of obesity and breast cancer outcomes in a population
Externí odkaz:
https://doaj.org/article/deff88c5dd3b427ea995096246bd0060
Publikováno v:
PharmacoEconomics - Open. 6:539-548
Breast cancer requires the greatest expenditure among all cancer types, and the costs vary by cancer stage and biomarker status.This study aimed to examine the differences in public healthcare costs of breast cancer in New Zealand by stage and subtyp
Publikováno v:
Asia-Pacific Journal of Clinical Oncology.
The pressure to the healthcare system for providing ongoing monitoring and treatment for breast cancer survivors is increasing. This study aims to identify the factors that affect the public healthcare costs of stage I-III breast cancer and stage IV
Publikováno v:
Menopause. 28:1085-1092
Objective Menopausal status at diagnosis is an important factor for the management of breast cancer in younger women, and may affect the prognosis for these women. We aim to examine the association of menopausal status and risk of metastatic relapse
Publikováno v:
Cancer Causes & Control. 32:753-761
This study aims to investigate the factors that influence the risk of metastatic relapse in women presenting with stage I-III breast cancer in New Zealand. The study included women diagnosed with stage I–III breast cancer. Cumulative incidence of d
Autor:
Oliver William Scott, Sandar Tin Tin, J. Mark Elwood, Alana Cavadino, Laurel A. Habel, Marion Kuper-Hommel, Ian Campbell, Ross Lawrenson
Purpose Beta blockers (BB) have been associated with improved, worsened, or unchanged breast cancer outcomes in previous studies. This study examines the association between the post-diagnostic use of BBs and death from breast cancer in a large, repr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9189691a2e352f968d09f2838d723f0e
https://doi.org/10.21203/rs.3.rs-1106678/v1
https://doi.org/10.21203/rs.3.rs-1106678/v1
Autor:
Chunhuan, Lao, Mohana, Mondal, Marion, Kuper-Hommel, Ian, Campbell, Michael P, Cameron, Ross, Lawrenson
Publikováno v:
The New Zealand medical journal. 134(1545)
This study aims to estimate the mean costs of breast cancer in New Zealand's public health system.This study included women diagnosed with invasive breast cancer between 1 July 2010 and 30 June 2018 who received services in public hospitals. These pa
Publikováno v:
The New Zealand medical journal. 134(1545)
To describe the systemic treatments in patients with de novo metastatic breast cancer (dnMBC, initial metastatic diagnosis) and recurrent metastatic breast cancer (rMBC).Women diagnosed with dnMBC and rMBC in 2010-2017 were identified. Adjusted odds
Autor:
J. Mark Elwood, Oliver W. Scott, Marion Kuper-Hommel, Ian Campbell, Ross Lawrenson, Diana Sarfati, Phyu Sin Aye, Sandar Tin Tin
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 17, Iss 7962, p 7962 (2020)
Volume 17
Issue 21
International Journal of Environmental Research and Public Health, Vol 17, Iss 7962, p 7962 (2020)
Volume 17
Issue 21
Background: Assessing the use of multiple medications in cancer patients is crucial as such use may affect cancer outcomes. This study reports the prevalence of non-cancer medication use at breast cancer diagnosis, its associated factors, and its eff